Product ID:FUROSEMIDE INJECTION;ESIPB113
MSDS Date:03/24/1993
FSC:6505
NIIN:01-157-5115
MSDS Number: BWSHH

ELKINS-SINN INC

2 ESTERBROOK LN
CHERRY HILL, NJ 08003
US

Emergency Phone: 609-424-3700

Info Phone: 609-424-3700 / FAX 609-424-8747

Cage: 51968

ELKINS-SINN INC

CHERRY HILL, NJ 08003-4099 US

Telephone: 800-257-8349/609-424-3700

Cage: 51968

ANTHRANILIC ACID,4-CHLORO-N-FURFURYL-5-SULFAMOYL

CAS: 54-31-9

RTECS: CB2625000

Fraction By Weight: 1%

WATER

CAS: 7732-18-5

RTECS: ZC0110000

Fraction By Weight: >1%

LD50 LC50 Mixture:ORAL LD50 (RAT) IS 2600 MG/KG
Routes of Entry: Inhalation:NO Skin:NO Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:EYES:MAY CAUSE IRRITATION.SKIN:NOT
REPORTED.LITERATURE DOES NOT SUGGEST DERMAL ABSORPTION AS A ROUTE
OF ENTRY.INGEST:MODERATELY TOXIC.LARGE DOSES MAY CAUSE PROFOUND
DIURESIS(URINATION) AND DEHYDRATION .INHAL:MAY CAUSE RESPIRATORY
IRRITATION.CHRONIC:MAY DAMAGE LIVER,PANCREAS AND KIDNEYS WITH
POSSIBLE HEARING LOSS.
Explanation of Carcinogenicity:FUROSEMIDE IS LISTED AS CLASS 3 BY
IARC(INADEQUATE EVIDENCE OF CARCINOGENICITY).
Effects of Overexposure:SYSTEMIC POISONING:DRY
MOUTH,THIRST,WEAKNESS,LETHARGY,MUSCLE
CRAMPS,ANOREXIA,NAUSEA,VOMITING,HYPOKALEMIA/HYPOCHLOREMIC
ACIDOSIS(SPECIFICALLY CAUSING
CONFUSION,CONVULSIONS,STUPOR,COMA,WEAK/RAPID PULSE, DEEP/RAPID
BREATHING)DIZZINESS,HYPOGLYCEMIA,CIRCULATORY DISTURBANCES.
Medical Cond Aggravated by Exposure:PERSONS WITH PRE-EXISTING
LIVER,KIDNEY AILMENTS,DIABETES,RESTRICTED SALT INTAKE OR
SUSCEPTIBILITY TO GOUT MAY BE AT INCREASED RISK FROM
EXPOSURE.ALCOHOL MAY INTENSIFY THE ACTION OF THIS DRUG.

First Aid:SKIN:REMOVE CONTAMINATED CLOTHING;WASH WITH SOAP OR MILD
DETERGENT AND WATER.EYES:FLUSH WITH NORMAL SALINE OR WATER FOR 15
MINUTES.INHAL:REMOVE TO FRESH AIR.GIVE OXYGEN OR ARTIFICIAL
RESPIRATION IF NE EDED.INGEST:DO NOT INDUCE VOMITING.GET PROMPT
QUALIFIED MEDICAL ATTENTION.IF SPONTANEOUS VOMITING OCCUR,KEEP HEAD
LOWER THAN HIPS.

Flash Point:NONE
Extinguishing Media:USE MEDIA APPROPRIATE FOR SURROUNDING FIRE.
Fire Fighting Procedures:USE A SELF-CONTAINED BREATHING APPARATUS AND
FULL PROTECTIVE EQUIPMENT.
Unusual Fire/Explosion Hazard:FIRE CONDITIONS MAY EVOLVE TOXIC FUMES.

Spill Release Procedures:SOAK UP WITH NON-COMBUSTIBLE INERT
ADSORBANT(EG.CLAY);PLACE COLLECTED MATERIAL IN AN APPROPRIATE
CONTAINER FOR DISPOSAL;CLEAN SPILL AREA TO REMOVE SLIPPERINESS.
Neutralizing Agent:NOT APPLICABLE.

Handling and Storage Precautions:STORE IN A COOL,DRY,WELL-VENTILATED
PLACE.KEEP CONTAINER CLOSED WHEN NOT IN USE.KEEP AWAY FROM
INCOMPATIBLE MATERIALS.
Other Precautions:FOLLOW LABEL DIRECTIONS.AVOID BREATHING VAPORS.AVOID
SKIN AND EYE CONTACT.

Respiratory Protection:WHERE ENVIRONMENTAL CONTROLS ARE LACKING OR IN
ENCLOSED SPACES USE A NIOSH/MSHA APPROVED RESPIRATOR FOR DUST AND
ORGANIC VAPORS.
Ventilation:LOCAL VENTILATION AT THE WORKSITE;MECHANICAL(GENERAL)
VENTILATION TO MAINTAIN TLV/PEL.
Protective Gloves:IMPERVIOUS,AS NEEDED.
Eye Protection:CHEMICAL SPLASH GOGGLES
Other Protective Equipment:PROTECTIVE CLOTHING,AS NEEDED.PROVIDE A
LOCAL EYE WASH STATION AND SAFETY SHOWER.
Work Hygienic Practices:USE REASONABLE CARE IN HANDLING THIS
PRODUCT.WASH HANDS AFTER USE AND BEFORE EATING.
Supplemental Safety and Health
THIS MEDICATION HAS CROSS REACTIVITY WITH OTHER SULFONAMIDES.

HCC:B3
pH:8-9.3
Solubility in Water:COMPLETE
Appearance and Odor:LIQUID,CLEAR.COLOR AND ODOR NOT REPORTED.

Stability Indicator/Materials to Avoid:YES
ACIDS,BASES,OXIDIZERS.
Stability Condition to Avoid:NONE SPECIFIED BY MANUFACTURER.
Hazardous Decomposition Products:UNIDENTIFED TOXIC SUBSTANCES.

Waste Disposal Methods:DISPOSE OF IN ACCORDANCE WITH FEDERAL,STATE AND
LOCAL REGULATIONS.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.